Table 5.
Imatinib Dose at 48 Months Follow-up by Pre-Existing Organ Function
Imatinib | Evaluable Patient | Imatinib Dose at 48 Months, No. (%) | |||
---|---|---|---|---|---|
300 mg | 400 mg | 600 mg | 800 mg | ||
400 mg | Renal dysfunction (n=2) | 0 (0) | 1 (50) | 0 (0) | 1 (50) |
Liver dysfunction (n=4) | 0 (0) | 4 (100) | 0 (0) | 0 (0) | |
Normal (n=26) | 3 (11) | 22 (85) | 1 (4) | 0 (0) | |
800 mg | Renal dysfunction (n=6) | 1 (17) | 2 (33) | 2 (33) | 1 (17) |
Liver dysfunction (n=21) | 0 (0) | 2 (10) | 5 (24) | 14 (66) | |
Normal (n=122) | 3 (3) | 20 (16) | 33 (27) | 66 (54) |